ATE201013T1 - Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen - Google Patents

Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen

Info

Publication number
ATE201013T1
ATE201013T1 AT96904495T AT96904495T ATE201013T1 AT E201013 T1 ATE201013 T1 AT E201013T1 AT 96904495 T AT96904495 T AT 96904495T AT 96904495 T AT96904495 T AT 96904495T AT E201013 T1 ATE201013 T1 AT E201013T1
Authority
AT
Austria
Prior art keywords
acids
phenylalkeneic
phenylalkaneous
ethylesters
triglycerides
Prior art date
Application number
AT96904495T
Other languages
English (en)
Inventor
Saul W Brusilow
Original Assignee
Brusilow Entpr Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23519346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE201013(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brusilow Entpr Llc filed Critical Brusilow Entpr Llc
Application granted granted Critical
Publication of ATE201013T1 publication Critical patent/ATE201013T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96904495T 1995-02-07 1996-02-06 Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen ATE201013T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38493595A 1995-02-07 1995-02-07
PCT/US1996/000940 WO1996024571A1 (en) 1995-02-07 1996-02-06 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders

Publications (1)

Publication Number Publication Date
ATE201013T1 true ATE201013T1 (de) 2001-05-15

Family

ID=23519346

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96904495T ATE201013T1 (de) 1995-02-07 1996-02-06 Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen

Country Status (9)

Country Link
US (3) US5968979A (de)
EP (1) EP0858441B1 (de)
AT (1) ATE201013T1 (de)
AU (1) AU4858796A (de)
CA (1) CA2212047C (de)
DE (1) DE69612755T2 (de)
ES (1) ES2157422T3 (de)
FR (1) FR16C0003I2 (de)
WO (1) WO1996024571A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642543B1 (en) 2000-09-26 2003-11-04 The Board Of Trustees Of The Leland Stanford Junior University Thin and thick gate oxide transistors on a functional block of a CMOS circuit residing within the core of an IC chip
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20040229948A1 (en) * 2002-04-12 2004-11-18 Summar Marshall L. Method for preventing hepatic encephalopathic episodes
US20030195255A1 (en) * 2002-04-12 2003-10-16 Summar Marshall L. Method for treating hepatic encephalopathies
WO2003099272A1 (en) 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
CA2506504A1 (en) 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US20090260743A1 (en) * 2003-11-21 2009-10-22 William David Mawby Tire manufacturing method for improving the uniformity of a tire
US20060160902A1 (en) * 2004-11-08 2006-07-20 Wiech Norbert L Histone deacetylase inhibitors
US8642012B2 (en) 2008-04-29 2014-02-04 Hyperion Therapeutics, Inc. Methods of treatment using ammonia-scavenging drugs
HRP20161222T1 (hr) * 2008-08-29 2017-02-10 Horizon Therapeutics, Llc Postupci liječenja koristeći lijekove za izbacivanje amonijaka
EP2760479B1 (de) 2011-09-30 2017-05-03 Horizon Therapeutics, LLC Stickstoffentfernender wirkstoff zur verwendung in einem verfahren zur behandlung einer stickstoffretentionsstörung
AU2012377389A1 (en) 2012-04-20 2014-10-30 Horizon Therapeutics Llc Methods of therapeutic monitoring of phenylacetic acid prodrugs
DK2922576T3 (en) * 2012-11-21 2018-01-15 Horizon Therapeutics Llc PROCEDURES FOR THE ADMINISTRATION AND EVALUATION OF NITROGEN RINSE MEDICINES FOR TREATING HEPATIC ENCYPHALOPATHY
HUE045106T2 (hu) 2013-10-14 2019-12-30 Immedica Pharma Ab Eljárások a karbamidciklus rendellenességeinek kezelésére
IN2013MU03442A (de) 2013-10-30 2015-07-17 Lupin Ltd
MX383005B (es) * 2013-11-14 2025-03-13 Ultragenyx Pharmaceutical Inc Composiciones solidas de trigliceridos y usos de estas.
EP3137116B1 (de) 2014-04-30 2020-12-16 The Johns Hopkins University Dendrimerzusammensetzungen und deren verwendung bei der behandlung von erkrankungen des auges
CN106573070A (zh) 2014-08-13 2017-04-19 约翰霍普金斯大学 树枝状聚合物到脑肿瘤的选择性传递
JP7088473B2 (ja) 2015-10-29 2022-06-21 ザ・ジョンズ・ホプキンス・ユニバーシティー ペルオキシソーム障害および白質ジストロフィーの処置のための組成物および方法
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
CN115103690B (zh) 2019-12-04 2026-01-23 阿什瓦塔治疗股份有限公司 用于将药物递送至眼的树枝状大分子组合物和方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders

Also Published As

Publication number Publication date
AU4858796A (en) 1996-08-27
EP0858441B1 (de) 2001-05-09
WO1996024571A1 (en) 1996-08-15
US6060510A (en) 2000-05-09
CA2212047A1 (en) 1996-08-15
US6083984A (en) 2000-07-04
ES2157422T3 (es) 2001-08-16
FR16C0003I2 (fr) 2016-06-24
US5968979A (en) 1999-10-19
EP0858441A4 (de) 1998-08-19
DE69612755T2 (de) 2001-08-23
DE69612755D1 (de) 2001-06-13
EP0858441A1 (de) 1998-08-19
CA2212047C (en) 2010-11-16
FR16C0003I1 (de) 2016-03-25

Similar Documents

Publication Publication Date Title
ATE201013T1 (de) Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen
DK1138325T3 (da) Anvendelse af syntetiske triglycerider på basis af konjugeret linolsyre til fremstilling af midler til støtte for tumorbehandlingen
DE69805846D1 (de) Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom
DE60237148D1 (de) Fettalkohole und fettsäureester zur behandlung von entzündungen
NO991342L (no) Anvendelse av fumarsyrederivater ved behandling av autoimmune sykdommer
EA200300830A1 (ru) Незаменимые n-3 жирные кислоты в лечении сердечной недостаточности и сердечной декомпенсации
ES2122076T3 (es) Derivados de nor-acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
ATE382051T1 (de) Prodrugs von pharmazeutika mit erhöhter bioverfügbarheit
ATE106867T1 (de) 13-trans-retinsäureester.
ATE397580T1 (de) Verwendung von ingenan derivaten zur herstellung eines medikaments zur krebsbekämpfung
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
NO20034782L (no) Farmasöytisk aktive uridinestere
FI20060154A7 (fi) Neurogeneratiivisten tilojen hoito
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
DE69302883D1 (de) L-Carnitin- und Alkanoyl-L-Carnitin-Ester mit Glykolsäure oder ihre Ester und diese enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
MX9203945A (es) Esteres bisfosfonicos de pirazolpirimidina y pirimidinilo como antiinflamatorios
DE69832520D1 (de) Verwendung von konjugierten linoleinsäure zur behandlung von type ii diabetes
DE69806622D1 (de) Kosmetische formulierungen zur verhütung und behandlung von haarausfall
PT977560E (pt) Tioesteres de ibuprofeno como inibidores de formacao de mediadores de inflamacaoe da dor dependente de nf-kb
ATE469907T1 (de) Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen
ATE245433T1 (de) Verwendung von lipopeptiden oder lipoproteinen zur wundbehandlung
ATE463242T1 (de) Behandlung von inkontinenz
ATE297722T1 (de) Verwendung von gaba analoga wie gabapentin zur herstellung eines medikaments für die behandlung von entzündungserkrankungen
DE69207479D1 (de) Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen
DE69924146D1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties